Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. The company has a relatively low valuation and long track record of top-line growth. They also hold good levels of cash. A more stable stock relatively. Can add to CTS here. Unlock Premium - Try 5i Free
Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. The Edmonton airport deal is positive and the company continues to announce engagements over the last couple of months. Revenues are still low though it has hit $450K on a trailing twelve month basis last quarter. Unlock Premium - Try 5i Free
Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. The company develops and commercializes diagnostic tools to monitor heart disease. Minimal to no revenues so still very speculative. Largely in the development phase. They signed new contracts with GE Healthcare Corp and new patents are being filed. Unlock Premium - Try 5i Free
Billy Kawasaki’s Insights - Billy’s most-liked answers from 5i Research. It’s hard to time the market and 5i does not recommend trying. It’s okay to rebalance or re-weigh to more defensive positions to tweak investor views, however. Unlock Premium - Try 5i Free